NEWS

Recro Pharma presents Phase III bunionectomy clinical data for IV meloxicam

Friday, May 19, 2017

Recro Pharma presents Phase III bunionectomy clinical data for IV meloxicam at the American Pain Society 36th annual scientific meeting.

Recro Pharma - data from late-stage trial demonstrate iv meloxicam 30mg provides rapid and sustained pain relief following bunionectomy surgery.

 

Source: reuters.com

Other News